These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24952675)

  • 21. Tiredness in a patient treated with itraconazole.
    Nalla P; Dacruz TA; Obuobie K
    BMJ; 2017 Jan; 356():i6819. PubMed ID: 28126837
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatic Failure in a Patient Receiving Itraconazole for Pulmonary Histoplasmosis-Case Report and Literature Review.
    Pettit NN; Pisano J; Weber S; Ridgway J
    Am J Ther; 2016; 23(5):e1215-21. PubMed ID: 26291595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Level of evidence for therapeutic drug monitoring of itraconazole].
    Charles M; Le Guellec C; Richard D; Libert F;
    Therapie; 2011; 66(2):103-8. PubMed ID: 21635856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appearance of anaphylactic shock after long-term intravenous itraconazole treatment.
    Chen J; Song X; Yang P; Wang J
    Ann Pharmacother; 2009 Mar; 43(3):537-41. PubMed ID: 19261964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Olum R; Baluku JB; Kazibwe A; Russell L; Bongomin F
    PLoS One; 2020; 15(10):e0240374. PubMed ID: 33052954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart failure induced by itraconazole.
    Rodrigo-Troyano A; Mediavilla MM; Garin N; Güell R
    Med Clin (Barc); 2017 Jan; 148(2):69-70. PubMed ID: 27914674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole Induced Congestive Heart Failure, A Case Study.
    Abraham AO; Panda PK
    Curr Drug Saf; 2018; 13(1):59-61. PubMed ID: 28971777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of aspergillus bronchitis with effective oral itraconazole].
    Oonakahara K; Mizoguchi A; Iwami F; Kawabata M; Osame M
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):282-7. PubMed ID: 12795183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhabdomyolysis after the administration of itraconazole to an asthmatic patient with bronchopulmonary aspergillosis.
    Ferrari M; Bodini I; Lo Cascio V
    Respiration; 2004; 71(3):289-91. PubMed ID: 15133351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical efficacy and cardiac safety of itraconazole injection in treatment of acute pulmonary invasive fungal infection in chronic pulmonary diseases in the elderly].
    Jia W; Li YC; Zhu YQ; Li GH; Zhou YL; Zhang DR; Zhao XY; Gao SL
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):230-3. PubMed ID: 20450657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
    Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA; Maertens J; Van Der Geest R; Bosly A; Michaux JM; Van Hoof A; Cleeren M; Wostenborghs R; De Beule K
    Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
    Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A high concentration of itraconazole in an aspergilloma].
    Niwa H; Yamakawa Y; Kondo K; Kiriyama M; Kondo S; Kani H; Masaoka A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):67-70. PubMed ID: 8717294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two cases of invasive pulmonary aspergillosis successfully treated with combination of antifungal agents].
    Okada H; Mochizuki Y; Nakahara Y; Kawamura T; Sasaki S
    Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):912-7. PubMed ID: 19882915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of secondary invasive pulmonary aspergillosis originating from an aspergilloma, successfully treated with itraconazole].
    Nakagawa Y; Shimazu K; Ebihara M; Amann K
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):294-8. PubMed ID: 9656680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.
    Poirier JM; Berlioz F; Isnard F; Cheymol G
    Therapie; 1996; 51(2):163-7. PubMed ID: 8763051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
    Stevens DA; Schwartz HJ; Lee JY; Moskovitz BL; Jerome DC; Catanzaro A; Bamberger DM; Weinmann AJ; Tuazon CU; Judson MA; Platts-Mills TA; DeGraff AC
    N Engl J Med; 2000 Mar; 342(11):756-62. PubMed ID: 10717010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
    Buckner SL; Ceesay MM; Pagliuca A; Morgan PE; Flanagan RJ
    Ther Drug Monit; 2011 Dec; 33(6):735-41. PubMed ID: 22105591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.